We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.1B
AUM Growth
-$646M
(-3.6%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-9.46%
Top 10 Holdings %
Top 10 Hldgs %
3.13%
Holding
5,006
New
607
Increased
1,563
Reduced
1,808
Closed
822
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$62M |
| 2 |
Amazon
AMZN
|
+$53.3M |
| 3 |
CVS Health
CVS
|
+$40.3M |
| 4 |
PayPal
PYPL
|
+$34.8M |
| 5 |
McDonald's
MCD
|
+$34.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$56.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$43.4M |
| 3 |
Charter Communications
CHTR
|
+$42.4M |
| 4 |
Comcast
CMCSA
|
+$40.3M |
| 5 |
Mastercard
MA
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.54% |
| 2 | Technology | 11.9% |
| 3 | Consumer Discretionary | 9.76% |
| 4 | Healthcare | 8.91% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
SGHC Ltd
SGHC
$6.55B
| $42K | ﹤0.01% |
+14,000
| New | +$49.6K |
|
3927
EyePoint Inc
EYPT
$1.13B
| $41.6K | ﹤0.01% |
11,886
-266
| -2% | -$1.17K |
|
3928
Comscore
SCOR
$106M
| $41.5K | ﹤0.01% |
1,791
+766
| +75% | +$19.9K |
|
3929
Inseego
INSG
$87.7M
| $40.9K | ﹤0.01% |
+4,854
| New | +$72.9K |
|
|
LKFT
3930
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
| $40.8K | ﹤0.01% |
919
-2,239
| -71% | -$94.2K |
|
3931
Tenaya Therapeutics
TNYA
$165M
| $40.7K | ﹤0.01% |
20,261
-3,581
| -15% | -$8.74K |
|
|
AMAM
3932
DELISTED
Ambrx Biopharma Inc
AMAM
| $40.6K | ﹤0.01% |
+17,905
| New | +$20.5K |
|
3933
American Superconductor
AMSC
$1.5B
| $40.5K | ﹤0.01% |
+10,998
| New | +$43K |
|
3934
BBVA Argentina
BBAR
$3.53B
| $40.5K | ﹤0.01% |
+10,373
| New | +$32K |
|
3935
Century Therapeutics
IPSC
$357M
| $39.8K | ﹤0.01% |
+7,762
| New | +$73.3K |
|
3936
CALL
TJX Companies
TJX
$175B
| $39.8K | ﹤0.01% |
+500
| New | +$36.9K |
|
3937
MiMedx Group
MDXG
$622M
| $39.3K | ﹤0.01% |
14,147
-11,364
| -45% | -$34K |
|
3938
UWM Holdings
UWMC
$478M
| $37.5K | ﹤0.01% |
11,325
-5,571
| -33% | -$20.9K |
|
3939
Carter's
CRI
$1.48B
| $37K | ﹤0.01% |
496
-34,278
| -99% | -$2.46M |
|
3940
Lifecore Biomedical
LFCR
$176M
| $36.4K | ﹤0.01% |
5,613
+5,277
| +1,571% | +$43.5K |
|
|
FRG
3941
DELISTED
Franchise Group, Inc.
FRG
| $36.2K | ﹤0.01% |
1,521
-38,648
| -96% | -$1.01M |
|
3942
Wheels Up
UP
$191M
| $35.3K | ﹤0.01% |
+172
| New | +$44.4K |
|
|
IVCPW
3943
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
| $35.3K | ﹤0.01% |
480,434
| – | – |
|
3944
FuboTV Inc
FUBO
$276M
| $35.1K | ﹤0.01% |
+1,681
| New | +$61.6K |
|
|
RBOT
3945
DELISTED
Vicarious Surgical
RBOT
| $34.9K | ﹤0.01% |
+577
| New | +$53.6K |
|
3946
Lexicon Pharmaceuticals
LXRX
$1.07B
| $34.8K | ﹤0.01% |
18,245
-4,600
| -20% | -$9.79K |
|
3947
Olema Pharmaceuticals
OLMA
$1.04B
| $34.6K | ﹤0.01% |
14,120
-23,194
| -62% | -$67.6K |
|
3948
Papa John's
PZZA
$785M
| $34.3K | ﹤0.01% |
417
-12,124
| -97% | -$953K |
|
|
EVA
3949
DELISTED
Enviva Inc.
EVA
| $34.1K | ﹤0.01% |
643
-5,166
| -89% | -$295K |
|
|
FLFVR
3950
DELISTED
Feutune Light Acquisition Corporation Right
FLFVR
| $34K | ﹤0.01% |
419,931
-1,000
| -0.2% | -$72 |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q4 2022 Portfolio in Review
As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.
- Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
- Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
- Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
- Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
- Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
- Cubist Systematic Strategies opened 607 new positions and closed 822 in Q4 2022.
- Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.
Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.